Epilepsy affects more than 50 million people worldwide, making it one of the most common neurological disorders. Although ...
The Food and Drug Administration recently approved gene therapy to treat sickle cell disease among children ages 2 and older, ...
Morning Overview on MSN
The FDA approved the first gene therapy for sickle cell in children as young as two
Regulators have opened a one-time gene therapy to some of the youngest patients with sickle cell disease. On July 1, 2026, ...
By Yiqing Wang/WHRO State lawmakers have budgeted nearly $15 million over two years to help Virginia Medicaid cover gene ...
Learn how gene editing is transforming sickle cell disease treatment and why expanding access to younger children matters.
A new study describes a gene therapy strategy that uses the brain's own glymphatic transport system to distribute engineered viral vectors throughout the brain.
Eric Boodman focuses on narrative features, exploring the startling ways that science and medicine affect people’s lives. You can reach Eric on Signal at eboodman.88. Katie covers the impact of health ...
The Food and Drug Administration on Thursday approved Regeneron's Otarmeni, the first gene therapy for genetic hearing loss. The drugmaker said it will offer the drug for free to U.S. patients.
From data lakes to streamlined production, Kriya, Opus, and Epicrispr discuss how technology is improving their operations.
Vijay Kumar, acting director of the office that reviews cell and gene therapies at the Food and Drug Administration, is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results